Heidelberg Pharma AG Inhaber-Aktien o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

33.33%

Market Cap

116.96 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.91 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE2.51 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 10:01:04 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW2.512.5
PREV. DAY'S PRICE2.5 (07/22)
CHANGE DAY BEFORE
+0.01
0.40 %
52 WEEK HIGH / LOW4.73 (07/29)2.31 (12/23)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.44-0.42-0.91--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
2.613.62---
PRICE - SALES RATIO
13.0416.3393.18--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A11QVV
ISIN
DE000A11QVV0
SYMBOL
HPHA
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Wilex
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
46.78 Mil.
MARKET CAPITALISATION
116.96 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-0.82 %
-1.57 %
-11.64 %
-15.82 %
-33.33 %
-33.24 %
-65.73 %
1.25 %
HIGH2.512.712.833.204.735.507.233.29
LOW2.362.362.362.362.312.102.102.36

Dividende

pro Aktie
Wilex does not deliver dividend information

Company profile

Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The firm focuses on oncology; and development Amanitin, a toxin used in cancer therapies. It also offers tumor implantation models, inflammatory and autoimmune diseases, and bioanalytics services. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

(in 84 days)
10/15/26Q3 2026 Sales and Revenue Release - Interim Management Statement